Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

8
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

319
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
319
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

8
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
8
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

431
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
431

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction-associated steatotic liver disease.

Journal of pediatric gastroenterology and nutrition·2026
Same author

Hypertransaminasemia Is a Marker of Severity in Children Hospitalized for Influenza.

Influenza and other respiratory viruses·2026
Same author

Metabolomic signatures supporting clinical stratification of Parkinson disease and atypical parkinsonism.

Parkinsonism & related disorders·2026
Same author

Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin deficient mice.

EMBO molecular medicine·2026
Same author

Withdrawal Note: Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice.

EMBO molecular medicine·2026
Same author

Clinical Features and Predictors of Severity in Children Hospitalized With Human Metapneumovirus: A Multicenter Italian Study.

The Pediatric infectious disease journal·2026

Related Experiment Video

Updated: Apr 24, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

17.2K

Emerging pathomechanisms involved in obesity.

Roberta D'Aniello1, Jacopo Troisi, Osvaldo D'Amico

  • 1*Department of Medicine and Surgery, Pediatrics Section, University of Salerno, Baronissi †Pediatrics Section, Local Health Service-ASL Salerno, Salerno, Italy.

Journal of Pediatric Gastroenterology and Nutrition
|September 9, 2014
PubMed
Summary

This study links childhood obesity to sleep issues, high fructose intake, and bisphenol A (BPA) exposure. These factors are emerging targets for preventing and treating pediatric obesity.

More Related Videos

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
03:07

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Published on: November 11, 2025

560
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

24.6K

Related Experiment Videos

Last Updated: Apr 24, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

17.2K
Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
03:07

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Published on: November 11, 2025

560
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

24.6K

Area of Science:

  • Pediatric Endocrinology
  • Environmental Health
  • Nutritional Science

Background:

  • Global rise in overweight and obesity, particularly in children.
  • Emerging evidence implicates sleep disturbances, high fructose diets, and endocrine disruptors like bisphenol A (BPA) in obesity.
  • Understanding these factors is crucial for effective pediatric obesity prevention and treatment.

Purpose of the Study:

  • To investigate the association between sleep deprivation/fragmentation, fructose consumption, BPA exposure, and childhood obesity.
  • To explore these factors as potential targets for preventive and therapeutic strategies in pediatric obesity.

Main Methods:

  • Clinical and anthropometric characterization of 54 Italian children (31 overweight/obese, 23 normal weight).
  • Parental questionnaires on obesogenic factors and childhood obesity.
  • Measurement of urinary bisphenol A (BPA) using gas chromatography/tandem mass spectrometry.
  • Correlation analysis using Spearman rank correlation.

Main Results:

  • Increased body mass index (BMI) correlated with sleep deprivation, nocturnal breathing problems, and daytime sleepiness.
  • Higher fructose consumption paralleled increased BMI and other anthropometric parameters.
  • Urinary BPA levels increased with BMI, while BPA conjugates showed an inverse trend; BPA correlated positively with disposable plastic reuse.

Conclusions:

  • Pilot study confirms a strong relationship between specific factors (sleep, fructose, BPA) and pediatric obesity.
  • These identified factors represent promising targets for future prevention and therapy strategies in childhood obesity.